You are here

Mylan

DOJ drops Viatris unit Mylan from industry-wide antitrust probe

Reuters

Tue, 07/2/24 - 11:20 am

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

Tue, 11/21/23 - 10:54 pm

Viatris maintains legal winning streak with yet another EpiPen antitrust victory

Fierce Pharma

Mon, 04/3/23 - 10:51 pm

AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort

Fierce Pharma

Tue, 05/3/22 - 10:47 am

Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute

Reuters

Thu, 03/17/22 - 10:25 am

multiple sclerosis

Biocon buys Viatris biosimilars for $3.3bn, eyes IPO

Pharmaforum

Mon, 02/28/22 - 09:20 am

Viatris to close former Novartis site in California in January, lay off 75

Fierce Pharma

Tue, 10/12/21 - 11:07 am

drug manufacturing

Former Mylan executive from McDonald pleads guilty to insider trading

Trib Live, PA

Mon, 09/20/21 - 12:05 am

insider trading

A pharma merger's impact ripples across West Virginia as Viatris plant closes

BioPharma Dive

Sat, 07/31/21 - 10:20 pm

drug manufacturing

Pfizer, Mylan escape another EpiPen lawsuit after judge scraps pharmacy chain's antitrust complaints

Fierce Pharma

Tue, 07/27/21 - 04:27 pm

Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

Reuters

Fri, 07/16/21 - 11:07 am

Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats

Fierce Pharma

Thu, 07/1/21 - 11:08 pm

Teva Pharmaceutical

Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial

Fierce Pharma

Fri, 06/25/21 - 11:09 am

Sanofi looks to take Mylan to court, again, over EpiPen antitrust allegations

Fierce Pharma

Wed, 06/2/21 - 12:14 pm

Teva, Mylan and fellow valsartan makers have to face consumer fraud claims: judge

Fierce Pharma

Mon, 02/1/21 - 11:07 pm

Teva Pharmaceutical

Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit

Motley Fool

Sun, 11/1/20 - 01:33 pm

Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio

Endpoints

Tue, 09/8/20 - 10:55 am

Aspen Pharmacare

FDA scolds Mylan for 'repeated' manufacturing problems

BioPharma Dive

Fri, 09/4/20 - 10:18 am

drug manufacturing

Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought

Center for Biosimilars

Tue, 09/1/20 - 10:44 am

Mylan yanks four lots of heart health, hemophilia injectables over packaging mix-up

Fierce Pharma

Mon, 08/31/20 - 09:03 pm

product recalls

Pages